These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17460484)

  • 1. Functional consequences of NOD2/CARD15 mutations in Crohn disease.
    Quaglietta L; te Velde A; Staiano A; Troncone R; Hommes DW
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):529-39. PubMed ID: 17460484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical applications of NOD2/CARD15 mutations in Crohn's disease.
    Barreiro-de Acosta M; Peña AS
    Acta Gastroenterol Latinoam; 2007 Mar; 37(1):49-54. PubMed ID: 17486745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ileal lymphonodular hyperplasia is not associated with NOD2/CARD15 mutations.
    Shaoul R; Eliakim R; Tamir A; Karban A
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43(1):30-4. PubMed ID: 16819374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
    Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
    Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease.
    Sabate JM; Ameziane N; Lamoril J; Jouet P; Farmachidi JP; Soulé JC; Harnois F; Sobhani I; Jian R; Deybach JC; de Prost D; Coffin B
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):748-55. PubMed ID: 18617779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of CARD15/NOD2 mutations in the Sicilian population.
    Renda MC; Cottone M
    Am J Gastroenterol; 2008 Jan; 103(1):248-9. PubMed ID: 18184136
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification, evolution, and association study of a novel promoter and first exon of the human NOD2 (CARD15) gene.
    King K; Bagnall R; Fisher SA; Sheikh F; Cuthbert A; Tan S; Mundy NI; Rosenstiel P; Schreiber S; Mathew CG; Roberts RG
    Genomics; 2007 Oct; 90(4):493-501. PubMed ID: 17719742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOD2 mutation and mice: no Crohn's disease but many lessons to learn.
    Wehkamp J; Stange EF
    Trends Mol Med; 2005 Jul; 11(7):307-9. PubMed ID: 15955743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CARD15/NOD2 mutations in Crohn's disease.
    Hugot JP
    Ann N Y Acad Sci; 2006 Aug; 1072():9-18. PubMed ID: 17057186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nod1 and Nod2 in innate immunity and human inflammatory disorders.
    Le Bourhis L; Benko S; Girardin SE
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1479-84. PubMed ID: 18031249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulomatous rosacea and Crohn's disease in a patient homozygous for the Crohn-associated NOD2/CARD15 polymorphism R702W.
    van Steensel MA; Badeloe S; Winnepenninckx V; Vreeburg M; Steijlen PM; van Geel M
    Exp Dermatol; 2008 Dec; 17(12):1057-8. PubMed ID: 18616576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired innate immunity in Crohn's disease.
    Comalada M; Peppelenbosch MP
    Trends Mol Med; 2006 Sep; 12(9):397-9. PubMed ID: 16890491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of NOD2/CARD15 mutations in Malaysian patients with Crohn's disease.
    Chua KH; Hilmi I; Ng CC; Eng TL; Palaniappan S; Lee WS; Goh KL
    J Dig Dis; 2009 May; 10(2):124-30. PubMed ID: 19426395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate immunity in Crohn's disease: the reverse side of the medal.
    Dessein R; Chamaillard M; Danese S
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S144-7. PubMed ID: 18806708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NOD2-associated diseases: Bridging innate immunity and autoinflammation.
    Borzutzky A; Fried A; Chou J; Bonilla FA; Kim S; Dedeoglu F
    Clin Immunol; 2010 Mar; 134(3):251-61. PubMed ID: 19467619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CARD15 variants determine a disturbed early response of monocytes to adherent-invasive Escherichia coli strain LF82 in Crohn's disease.
    Peeters H; Bogaert S; Laukens D; Rottiers P; De Keyser F; Darfeuille-Michaud A; Glasser AL; Elewaut D; De Vos M
    Int J Immunogenet; 2007 Jun; 34(3):181-91. PubMed ID: 17504508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunology of Crohn's disease.
    Braat H; Peppelenbosch MP; Hommes DW
    Ann N Y Acad Sci; 2006 Aug; 1072():135-54. PubMed ID: 17057196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complex interplay of NOD-like receptors and the autophagy machinery in the pathophysiology of Crohn disease.
    Billmann-Born S; Lipinski S; Böck J; Till A; Rosenstiel P; Schreiber S
    Eur J Cell Biol; 2011; 90(6-7):593-602. PubMed ID: 21146253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inflammatory bowel diseases: an immunological approach].
    Sepúlveda SE; Beltrán CJ; Peralta A; Rivas P; Rojas N; Figueroa C; Quera R; Hermoso MA
    Rev Med Chil; 2008 Mar; 136(3):367-75. PubMed ID: 18575665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.